Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Temporal perturbations in sonic hedgehog signaling elicit the spectrum of holoprosencephaly phenotypes
Dwight Cordero, … , Minal Tapadia, Jill A. Helms
Dwight Cordero, … , Minal Tapadia, Jill A. Helms
Published August 16, 2004
Citation Information: J Clin Invest. 2004;114(4):485-494. https://doi.org/10.1172/JCI19596.
View: Text | PDF
Article Development

Temporal perturbations in sonic hedgehog signaling elicit the spectrum of holoprosencephaly phenotypes

  • Text
  • PDF
Abstract

One of the most perplexing questions in clinical genetics is why patients with identical gene mutations oftentimes exhibit radically different clinical features. This inconsistency between genotype and phenotype is illustrated in the malformation spectrum of holoprosencephaly (HPE). Family members carrying identical mutations in sonic hedgehog (SHH) can exhibit a variety of facial features ranging from cyclopia to subtle midline asymmetries. Such intrafamilial variability may arise from environmental factors acting in conjunction with gene mutations that collectively reduce SHH activity below a critical threshold. We undertook a series of experiments to test the hypothesis that modifying the activity of the SHH signaling pathway at discrete periods of embryonic development could account for the phenotypic spectrum of HPE. Exposing avian embryos to cyclopamine during critical periods of craniofacial development recreated a continuum of HPE-related defects. The craniofacial malformations included hypotelorism, midfacial hypoplasia, and facial clefting and were not the result of excessive crest cell apoptosis. Rather, they resulted from molecular reprogramming of an organizing center whose activity controls outgrowth and patterning of the mid and upper face. Collectively, these data reveal one mechanism by which the variable expressivity of a disorder such as HPE can be produced through temporal disruption of a single molecular pathway.

Authors

Dwight Cordero, Ralph Marcucio, Diane Hu, William Gaffield, Minal Tapadia, Jill A. Helms

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Cyclopamine elicits a spectrum of HPE defects. (A) Cyclopamine administr...
Cyclopamine elicits a spectrum of HPE defects. (A) Cyclopamine administration at St. 22 has no discernible effect on craniofacial development relative to (B) HBC (and untreated) controls. Note equivalent size of the premaxilla (pm) in cyclopamine and control embryos. (C) If cyclopamine is delivered at St. 20, the premaxilla fails to extend; compare dotted line with that in (D). (E) When cyclopamine is administered at St. 17, the distal tip of the upper beak fails to form (arrow), the midface is hypoplastic, and embryos are microcephalic. Proximal facial structures and the mandible (mn) are unaffected compared with controls (F). (G) Cyclopamine exposure at St. 15 results in a compressed mediolateral facial axis (red arrow). Note single telencephalic (te) bulge and a severely reduced frontonasal primordium (fnp), which causes the nasal pits (np) to approximate in the midline and the eyes to deviate medially; control is shown in (H). The dorsoventral facial axis is also distorted, as indicated by the proximity of Rathke’s pouch to the frontonasal primordium, which effectively eliminates the roof of the oral cavity. The maxillary and mandibular primordia are either absent or greatly reduced. (I) Cyclopamine delivery at St. 10 causes an arrest in midline growth, resulting in fused telencephalic vesicles and nasal pits, which create a proboscis. Midline entities such as the frontonasal primordium fail to develop compared with HBC controls (J). The majority of embryos die within 24 hours of treatment. Scale bars: 1.0 mm (A–F, I, and J); 2.0 mm (G and H). tx, treatment.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts